High Tech Financials
| 106190 Stock | KRW 14,300 150.00 1.06% |
High |
Understanding current and past High Tech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of High Tech's financial statements are interrelated, with each one affecting the others. For example, an increase in High Tech's assets may result in an increase in income on the income statement.
Please note, the presentation of High Tech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, High Tech's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of High Tech's management manipulating its earnings.
High Tech Stock Summary
High Tech competes with Kolon Life, Aminologics CoLtd, Withuspharmaceutical, and . High Tech Pharm Co., Ltd. develops, manufactures, sells, and distributes antibiotic pharmaceutical ingredients for injections for hospitals and doctors.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7106190002 |
| Business Address | 280, Sinnae-Ro, Daeso-Myeon, |
| Industry | Pharmaceuticals |
| Benchmark | Dow Jones Industrial |
| Website | www.htpharm.com |
| Phone | 82 4 3883 0012 |
| Currency | KRW - South Korean Won |
You should never invest in High Tech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of High Stock, because this is throwing your money away. Analyzing the key information contained in High Tech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
High Tech Key Financial Ratios
High Tech's financial ratios allow both analysts and investors to convert raw data from High Tech's financial statements into concise, actionable information that can be used to evaluate the performance of High Tech over time and compare it to other companies across industries.| Return On Equity | 0.0057 | |||
| Return On Asset | 6.0E-4 | |||
| Target Price | 26000.0 | |||
| Beta | 0.74 | |||
| Z Score | 9.6 |
High Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining High Tech's current stock value. Our valuation model uses many indicators to compare High Tech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across High Tech competition to find correlations between indicators driving High Tech's intrinsic value. More Info.High Tech Pharm is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers reporting about 0.11 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for High Tech Pharm is roughly 9.50 . Comparative valuation analysis is a catch-all model that can be used if you cannot value High Tech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for High Tech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.High Tech Pharm Systematic Risk
High Tech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. High Tech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on High Tech Pharm correlated with the market. If Beta is less than 0 High Tech generally moves in the opposite direction as compared to the market. If High Tech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one High Tech Pharm is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of High Tech is generally in the same direction as the market. If Beta > 1 High Tech moves generally in the same direction as, but more than the movement of the benchmark.
High Tech November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of High Tech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of High Tech Pharm. We use our internally-developed statistical techniques to arrive at the intrinsic value of High Tech Pharm based on widely used predictive technical indicators. In general, we focus on analyzing High Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build High Tech's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 11.21 | |||
| Value At Risk | (4.91) | |||
| Potential Upside | 4.35 |
Complementary Tools for High Stock analysis
When running High Tech's price analysis, check to measure High Tech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy High Tech is operating at the current time. Most of High Tech's value examination focuses on studying past and present price action to predict the probability of High Tech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move High Tech's price. Additionally, you may evaluate how the addition of High Tech to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |